Andrew Miranker, Professor of Molecular Biophysics & Biochemistry is named a finalist for the Blavatnik Fund, highlighting promising research across Yale

June 1, 2017

Congratulations to Andrew Miranker who was one of seventeen applications from Yale innovators have been named finalist for grants and resources from the Blavatnik Fund for Innovation at Yale, competing for up to $300,000 in Development grants or up to $100,000 in Pilot grants to accelerate their life science research into the marketplace. The $10 million fund supported by the Blavatnik Family Foundation launched this year to advance entrepreneurship in the life sciences at Yale and is managed by the Yale Office of Cooperative Research. Over 60 researchers applied for funding from across the Yale science disciplines, including chemistry, pharmacology, neuroscience, biomedical engineering, obstetrics, biophysics and immunobiology.